Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[A majority of useless call of an on-call urology resident: a study of the AFUF].
Koutlidis N, Fiard G, Brichart N, Souillac I, Lebacle C, Cerruti A, Terrasa JB, Bigot P, Branchereau J, Celhay O, Ripert T, Terrier JE, Beauval JB, Murez T, Fais PO, Bessede T. Koutlidis N, et al. Among authors: fiard g. Prog Urol. 2013 Jun;23(7):480-5. doi: 10.1016/j.purol.2013.03.006. Epub 2013 Apr 11. Prog Urol. 2013. PMID: 23721709 French.
Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?
Baboudjian M, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Gondran-Tellier B, Roumeguère T, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, VAN DEN Bergh RC, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: fiard g. Minerva Urol Nephrol. 2023 Feb;75(1):124-126. doi: 10.23736/S2724-6051.22.05121-7. Epub 2022 Oct 25. Minerva Urol Nephrol. 2023. PMID: 36282548 Free article. No abstract available.
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach.
Baboudjian M, Breda A, Roumeguère T, Uleri A, Roche JB, Touzani A, Lacetera V, Beauval JB, Diamand R, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, Durand-Labrunie C, Roumiguié M, Sanguedolce F, Oderda M, Barret E, Fromont G, Dariane C, Charvet AL, Gondran-Tellier B, Bastide C, Lechevallier E, Palou J, Ruffion A, Van Der Bergh RCN, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: fiard g. World J Urol. 2023 May;41(5):1301-1308. doi: 10.1007/s00345-023-04353-8. Epub 2023 Mar 15. World J Urol. 2023. PMID: 36920491
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
Baboudjian M, Roubaud G, Fromont G, Gauthé M, Beauval JB, Barret E, Brureau L, Créhange G, Dariane C, Fiard G, Mathieu R, Ruffion A, Rouprêt M, Renard-Penna R, Sargos P, Ploussard G; Prostate Cancer Committee of the French Association of Urology. Baboudjian M, et al. Among authors: fiard g. World J Urol. 2023 Aug;41(8):2033-2041. doi: 10.1007/s00345-022-04239-1. Epub 2022 Dec 9. World J Urol. 2023. PMID: 36484817 Review.
Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.
Baboudjian M, Gondran-Tellier B, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, van den Bergh RCN, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: fiard g. Eur Urol Oncol. 2023 Aug;6(4):406-413. doi: 10.1016/j.euo.2022.09.005. Epub 2022 Oct 21. Eur Urol Oncol. 2023. PMID: 36280445
Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study.
Windisch O, Benamran D, Dariane C, Favre MM, Djouhri M, Chevalier M, Guillaume B, Oderda M, Gatti M, Faletti R, Colinet V, Lefebvre Y, Bodard S, Diamand R, Fiard G. Windisch O, et al. Among authors: fiard g. Eur Urol Open Sci. 2022 Dec 15;47:94-101. doi: 10.1016/j.euros.2022.11.013. eCollection 2023 Jan. Eur Urol Open Sci. 2022. PMID: 36601048 Free PMC article.
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: fiard g. Prostate. 2023 May;83(6):572-579. doi: 10.1002/pros.24490. Epub 2023 Jan 27. Prostate. 2023. PMID: 36705314
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens.
Martini A, Touzani A, Beauval JB, Ruffion A, Olivier J, Gasmi A, Dariane C, Thoulouzan M, Barret E, Brureau L, Créhange G, Fiard G, Gauthé M, Renard-Penna R, Roubaud G, Sargos P, Roumiguié M, Timsit MO, Mathieu R, Villers A, Rouprêt M, Fromont G, Ploussard G; CC-AFU, Cancerology Committee of the Association Française d’Urologie. Martini A, et al. Among authors: fiard g. World J Urol. 2022 Dec;40(12):2931-2937. doi: 10.1007/s00345-022-04202-0. Epub 2022 Nov 7. World J Urol. 2022. PMID: 36342512
176 results